Genetic Cancer Test Granted FDA Breakthrough Device Designation
The designation’s accelerated regulatory review is intended to expedite use of the diagnostic in pharmaceutical trials.
Read More
Search Results for: lung cancer
Lab Readiness Program Speeds Cancer Patient Access to Combination Products
LabCorp joins Qiagen ‘Day-One’ lab readiness program designed to deliver precision medicine to patients faster.
Read MoreResearch Collaboration Aims to Improve Use of PCR Technology to Detect Cancer Recurrence
Patient-specific assays detect low-volume minimal residual disease at high levels of sensitivity and characterize the landscape of relapsing lung cancer.
Read More
Decision Expands Guardant360 Coverage to Most Solid Tumor Types
The draft LCD applies to advanced cancer patients who are covered by Medicare for next-generation sequencing of tumor tissue, but have insufficient or unavailable tissue samples.
Read More
Mayo Clinic Announces Collaboration to Develop Diagnostic for Lung Cancer
The tests will use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
Read More